Krystal Biotech

Developing and commercializing novel treatments for patients suffering from severe dermatological diseases

Krystal Biotech is a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from debilitating dermatological diseases. Krystal has developed a proprietary gene therapy platform, the Skin TARgeted Delivery platform (or STAR-D platform), that consists of a patent-pending engineered viral vector and skin-optimized gene transfer technology to develop off-the-shelf treatments for dermatological diseases for which the company believes there are no known effective treatments.

Status

NASDAQ: KRYS

Year of Investment

2018

Strategy

Life Sciences

Subsector

Development-Stage Therapeutics

Location

Pittsburgh, Pennsylvania